Really hard to believe after recent P1b trial results IMU is now valued at $40m MC after deducting cash.
The market is putting that valuation on a Platform Technology is has shown such good results in the trials.
Can we expect a solid update on the progress of trial participants? After their booster shots. That would seem to be next logical trigger point. Unless news from the US turns up?.
Anybody have some thoughts on possible announcements that might wake this back up.
Really hard to believe after recent P1b trial results IMU is now...
-
- There are more pages in this discussion • 140 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
